farnesol has been researched along with caryophyllene oxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boušová, I; Matoušková, P; Pávek, P; Šadibolová, M; Skálová, L; Smutný, T; Šubrt, Z; Zárybnický, T | 1 |
| Anzenbacher, P; Bazgier, V; Otyepka, M; Skálová, L; Špičáková, A | 1 |
2 other study(ies) available for farnesol and caryophyllene oxide
| Article | Year |
|---|---|
Sesquiterpenes Are Agonists of the Pregnane X Receptor but Do Not Induce the Expression of Phase I Drug-Metabolizing Enzymes in the Human Liver.
Topics: Aged; Aged, 80 and over; Aldo-Keto Reductases; Carbonyl Reductase (NADPH); Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Farnesol; Female; Hep G2 Cells; Hepatocytes; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Monocyclic Sesquiterpenes; Polycyclic Sesquiterpenes; Pregnane X Receptor; Receptors, Aryl Hydrocarbon; RNA, Messenger; Sesquiterpenes | 2019 |
beta-caryophyllene oxide and trans-nerolidol affect enzyme activity of CYP3A4 - in vitro and in silico studies.
Topics: Catalytic Domain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Farnesol; Humans; Microsomes, Liver; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Polycyclic Sesquiterpenes; Sesquiterpenes | 2019 |